Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

TargetRx hired Craig Scott as ceo and president;
Glaxo hired Lon Cardon to head its genetics organization;
Interleukin Genetics named Lewis Bender as ceo;
RxElite named Rick Schindewolf as vp, business development;
TNS Healthcare hired Ceri Thomas as exec vp, global accounts;
BioMarin Pharmaceutical hired Gordon Vehar from Genentech as vp of research;
Cerenis named Robert Scott as chief medical officer;
Cardiokine named Manuel Worce as ceo and president;
Lentigen hired Tim Ravenscroft from Bristol-Myers Squibb as its new ceo;
InNexus added J. Donald Capra to its board;
Barrier Therapeutics named coo Alfred Altomari to succeed Geert Cauwenbergh as ceo on March 31;
Generic Pharmaceutical Association hired US Senate staffer Lisa Layman as associate vp for gov’t affairs;
Institute for Pediatric Innovation hired Stephen Spielberg as principal investigator for its reformulation program;
Solvay Pharmaceuticals hired Stephen Hill as its new ceo as of April 30 to replace the retiring Larry Downey;
NPS Pharmaceuticals elected Peter Tombros as board chairman and Francois Nader as a director.